DOHA, Qatar, Nov. 13, 2024 /PRNewswire/ -- The 10th edition of the Aspire Academy Global Summit concluded in Qatar, bringing together leaders from 50 top football organisations worldwide.
Over two days, the summit provided a platform for exchanging groundbreaking insights on sports science, coaching techniques, and performance, with a key focus on inspiring the next generation of sporting stars.
Powerful Setting for Global Collaboration
The summit's first day concluded with a gala dinner for guests, the evening's highlight was a Star Chat with Italian basketball coach Sergio Scariolo, current head coach of the Spanish national basketball team. During his talk, Scariolo shared valuable coaching techniques and emphasized the importance of continual learning and building strong connections with players.
Earlier in the day the delegates had heard from Ajax Amsterdam's Italian coach Francesco Farioli, who is also a former coach at Aspire Academy as well as French coaches Rudi Garcia and Christophe Galtier.
Reflections on Evolution in Football
Former Argentina striker Gabriel Batistuta was unable to address the summit due to unforeseen circumstances, but the event continued with a series of engaging activities.
A key session focused on the evolution of football tactics over the past decade. Gerrard Trives Guardiola from Barcelona's Methodology Department discussed how the club's playing style has adapted after the departures of legends like Lionel Messi and Neymar. He stressed the importance of allowing young players to express themselves.
Jose Tavares, Academy Director at Porto FC, emphasized the need to anticipate future football trends to implement changes early and highlighted the significance of emotional moments in a player's journey as motivation.
The Future of Football Performance
Darragh Connolly, Head of Academy Performance at Juventus, highlighted the need for proper preparation of young players as academies expand. He noted that a football club's entire structure must align to equip players for professional challenges.
Rick Cost, Director of High Performance at US Soccer, discussed the rapid rise of Artificial Intelligence and its potential to enhance coaching and performance analysis while leveraging AI wisely.
The summit featured a special appearance by Aspire Academy graduate and four-time Olympic high jump medallist Mutaz Barshim.
Valter and the Aspire Fellows: Looking Ahead to the Next Edition
Professor Valter Di Salvo, Executive Director of the 2024 Aspire Global Summit thanked the delegates, and he is looking forward to hosting the 11th edition of the Summit.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
World's Top Football Clubs Conclude Aspire Academy's 10th Global Summit Under Qatar's Desert Stars
World's Top Football Clubs Conclude Aspire Academy's 10th Global Summit Under Qatar's Desert Stars
SEOUL, South Korea, Dec. 6, 2024 /PRNewswire/ -- SD Biosensor, Inc. (KQ137310), South Korea's global in-vitro diagnostics company, announced the signing of a tripartite memorandum of understanding (MOU) for the research and development (R&D) of new products targeting extensively drug-resistant tuberculosis using its Point-of-Care (POC) molecular diagnostic platform "STANDARD M10" (hereinafter, "M10"). The MOU was signed with the Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (hereinafter, "RIT/JATA"), and Korea's International Tuberculosis Research Center (hereinafter, "ITRC"), at SD Biosensor's Giheung Office on Nov. 28.
The signing ceremony was attended by HyoKeun Lee (Chief Executive Officer, SDB), Dr. Seiya Kato, (Director, RIT/JATA), and Sangrae Cho (Chief, ITRC), among others. Under this MOU, the three organizations plan to pursue active collaboration on: product research and development; performing research and verifying feasibility; product approval and commercialization, etc., all under the common goal of "research and development of new products for extensively drug-resistant tuberculosis".
"Extensively drug-resistant tuberculosis (XDR-TB)" refers to a form of tuberculosis that is resistant not only to primary drugs used for treatment (multidrug-resistant tuberculosis, MDR-TB, or rifampicin-resistant tuberculosis, RR-TB), but also to fluoroquinolone, a second-line drug, and at least one drug from Group A. The mortality rate of patients who develop resistance to these drugs is known to exceed 25%. Therefore, rapid diagnosis and the use of appropriate medications are crucial. The products for extensively drug-resistant tuberculosis, which will be developed through this MOU with SD Biosensor's POC molecular diagnostic platform M10 are expected to contribute to the eradication of tuberculosis in high-risk Asian countries.
Dr. Seiya Kato, the Director of RIT/JATA said, "We are proud to collaborate with SD Biosensor and the International Tuberculosis Research Center in the development of a molecular diagnostic kit for extensively drug-resistant tuberculosis. This innovation marks a significant step forward in accelerating accurate diagnosis and improving global tuberculosis control efforts."
Dr. Sundae Song, the Chairman of the Board of the ITRC stated, "It is truly meaningful to collaborate on the research and development of new tuberculosis products through this MOU with SD Biosensor, a leader in the global in-vitro diagnostics industry, and RIT/JATA, a world-renowned tuberculosis research institute." He added, "The rapid diagnostic technologies developed through this MOU are expected to significantly shorten the treatment duration for extensively drug-resistant tuberculosis and greatly improve treatment success rates."
HyoKeun Lee, the CEO of SD Biosensor said, "With this MOU as a turning point, we believe that through collaboration of the three parties, we will be able to develop even more innovative and high-performance M10 products for extensively drug-resistant tuberculosis, which will facilitate personalized medication prescriptions." He added, "By continuing exchanges and cooperation between Korea and Japan, we are determined to strengthen our diagnostic capabilities to enable early detection of patients not only in the two countries but across the entire Asian region, and contribute to the global efforts of tuberculosis eradication."
For relevant inquiries, please contact:
Manager Evie Baik, SD Biosensor, Inc. (E-mail: pr@sdbiosensor.com)
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
SD Biosensor Signs Tripartite MOU for R&D of New Products for Extensively Drug-Resistant Tuberculosis with Japan's RIT/JATA and Korea's International Tuberculosis Research Center
